Scott Tarriff - 10%+ Owner at Eagle Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
10%+ Owner
Stock Symbol
EGRX on Nasdaq
All Insider Reports
All Insider Reports

Scott Tarriff - trading volume in the past year for Eagle Pharmaceuticals, Inc.

Holdings reported by Scott Tarriff for Eagle Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 993K $6.22M $6.27 Feb 28, 2024 By Tarriff 2016 Generation Skipping Exempt Family Trust DTD 12/28/2016
Common Stock 461K $2.89M $6.27 Feb 28, 2024 Direct

Transactions reported by Scott Tarriff for Eagle Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.